Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators
STAFFORD, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutic...
Stay updated with breaking news from Trials Information System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
STAFFORD, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutic...
STAFFORD, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the
Following a public consultation period this summer, the European Medicines Agency (EMA) published revised transparency rules (s. here) for the EU Clinical Trials Information System...
Amsterdam, May 12, 2023 (GLOBE NEWSWIRE) -- RAPS Euro Convergence 2023 concluded on Friday, as a record 650-plus attendees gathered in Amsterdam for...
Amsterdam, May 12, 2023concluded on Friday, as a record 650-plus attendees gathered in Amsterdam for three days of learning and networking at the most comprehensive regulatory affairs conference in Europe. Last